Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award(A) | 2024-07-15 4:12 pm | N/A 2034-06-05 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-17 4:41 pm | N/A 2034-06-13 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 130,000 | $0 | 36,542,716 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:59 pm | N/A 2034-06-12 | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-06-10 Conversion | 2024-06-10 7:46 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 35,652,876 | $0 | 3,728,738 (Indirect) | View |
| 2024-06-06 Option Award | 2024-06-07 4:22 pm | N/A 2034-06-05 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 54,278 | $0 | 54,278 (Direct) | View |
Ownership | 2024-06-06 7:14 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 3,728,738 (Indirect) | View |
| 2024-05-30 Option Award | 2024-06-03 12:14 pm | 2025-05-30 2034-05-29 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director | 24,000 | $0 | 13,550,704 (Direct) | View |
| 2024-04-02 Conversion | 2024-04-04 4:30 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 4,851,442 | $0 | 1,181,766 (Indirect) | View |
Ownership | 2024-03-27 7:56 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 0 | $0 | 2,494,095 (Indirect) | View |
| 2023-12-08 Other | 2023-12-12 7:53 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 1,879,654 | $0 | 32,424,564 (Indirect) | View |
| 2023-09-19 Conversion | 2023-09-20 06:16 am | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 17,424,704 | $0 | 3,624,143 (Indirect) | View |
Ownership | 2023-09-14 9:29 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 0 | $0 | 28,045,420 (Indirect) | View |
| 2023-09-08 Option Award | 2023-09-08 4:24 pm | N/A 2033-09-07 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 55,000 | $0 | 36,467,716 (Direct) | View |
| 2023-07-28 Other | 2023-08-10 8:27 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | ARCH Venture Fund XI L.P. ARCH Venture Partners XI L.P. ARCH Venture Partners XI LLC NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,600,000 | $0 | 2,250,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-20 4:49 pm | N/A 2033-06-15 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 36,477,716 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:49 pm | N/A 2033-06-14 | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 39,062 | $0 | 39,062 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 5:42 pm | N/A 2033-06-07 | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-05-22 Option Award | 2023-05-24 4:16 pm | 2024-05-22 2033-05-21 | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 18,081 | $0 | 13,538,758 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-06 4:19 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 536 | $0 | 44,056,353 (Direct) | View |
| 2022-10-24 Conversion | 2022-10-26 8:01 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 41,410,655 | $0 | 16,080 (Indirect) | View |
Ownership(A) | 2022-10-24 4:40 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 0 | $0 | 16,080 (Indirect) | View |
Ownership | 2022-10-19 8:03 pm | N/A N/A | Prime Medicine Inc. | PRME | NELSEN ROBERT Director 10% Owner | 0 | $0 | 11,456,594 (Indirect) | View |
| 2022-10-05 Option Award | 2022-10-06 4:06 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director 10% Owner | 321 | $0 | 44,055,817 (Direct) | View |
| 2022-09-02 Other | 2022-09-07 8:30 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,333 | $0 | 1,662,347 (Indirect) | View |
| 2022-08-30 Other | 2022-09-01 5:22 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,346 | $0 | 1,604,027 (Indirect) | View |
| 2022-08-24 Other | 2022-08-26 5:15 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,058,346 | $0 | 1,545,681 (Indirect) | View |
| 2022-08-18 Other | 2022-08-22 5:15 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,173 | $0 | 958,162 (Indirect) | View |
| 2022-08-12 Other | 2022-08-16 9:05 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 1,587,519 | $0 | 1,987,335 (Indirect) | View |
| 2022-07-05 Option Award | 2022-07-07 4:30 pm | N/A N/A | Sana Biotechnology Inc. | SANA | NELSEN ROBERT Director | 266 | $0 | 44,055,496 (Direct) | View |
| 2022-06-08 Other | 2022-06-10 9:24 pm | N/A N/A | Vir Biotechnology Inc. | VIR | NELSEN ROBERT Director 10% Owner | 529,173 | $0 | 841,470 (Indirect) | View |
| 2022-06-08 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-07 | Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner | 65,000 | $0 | 36,477,716 (Direct) | View |